Sugi Predict

Sugi Predict / Compounds / SCHEMBL133647

SCHEMBL133647

SCHEMBL133647

O=C(O)c1cc(N=Nc2ccc([N+](=O)[O-])cc2)ccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 6/20 1.00
▸ ALDH1A1 P00352 6/20 1.00
▸ SMN1; SMN2 Q16637 1/20 1.00
▸ MEN1 O00255 6/20 0.70
▸ KMT2A Q03164 6/20 0.70
▸ HTT P42858 2/20 0.70
▸ BLVRB P30043 2/20 0.70
▸ PDE4A P27815 1/20 0.70
▸ KDR P35968 1/20 0.70
▸ RECQL P46063 2/20 0.67
▸ BLM P54132 2/20 0.67
▸ APP P05067 1/20 0.67
▸ THRB P10828 1/20 0.67
▸ PHLPP2 Q6ZVD8 4/20 0.62
▸ CYP2C9 P11712 2/20 0.62
▸ PTGS1 P23219 1/20 0.62
▸ PTGS2 P35354 1/20 0.62
▸ HSD17B10 Q99714 1/20 0.62
▸ TSHR P16473 2/20 0.58
▸ CYP2D6 P10635 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29359461 1.00 TDP1 (1.00) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL133646 1.00 TDP1 (1.00) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7033973 0.98 TDP1 (0.97) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7033980 0.98 TDP1 (0.97) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7033984 0.98 TDP1 (0.97) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL3101571 0.88 ALDH1A1 (0.78) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL3101576 0.88 ALDH1A1 (0.78) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL29481568 0.87 ALDH1A1 (0.77) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4047509 0.87 ALDH1A1 (0.77) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4051923 0.87 ALDH1A1 (0.77) TDP1ALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060173058-A1 Kcnq channel modulating compounds and their pharmaceutical use NEUROSEARCH A/S (DK) 2006-08-03 — — US claimed
EP-1603858-A2 KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE NeuroSearch A/S (DK) 2005-12-14 — — EP claimed
WO-2004080377-A2 KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE NEUROSEARCH A/S (DK) 2004-09-23 — — WO claimed
US-20030087451-A1 Acid test kit MAINSTREAM ENGINEERING CORP. 2003-05-08 — — US claimed
WO-1996033394-A1 ACID TEST KIT MAINSTREAM ENGINEERING CORPORATION (US) 1996-10-24 — — WO claimed
EP-3752201-B1 SUSPENSION OF NANOSCALE, ORGANIC PARTICLES AND PROCESS FOR PRODUCTION THEREOF UNIV FRIEDRICH ALEXANDER ER (DE) 2023-11-22 — — EP disclosed
US-11384381-B2 Reaction accelerating agent KIKKOMAN CORPORATION (JP) 2022-07-12 — — US disclosed
US-20220024825-A1 METHOD FOR ANALYSING THE QUANTITY OF CLAY IN A SAND STARCIN HOLDING FRANCE (FR) 2022-01-27 — — US disclosed
US-20210087495-A1 COLOR CHANGING DETERGENT COMPOSITIONS AND METHODS OF USE ECOLAB USA INC. 2021-03-25 — — US disclosed
US-20190316174-A1 REACTION ACCELERATING AGENT KIKKOMAN CORPORATION (JP) 2019-10-17 — — US disclosed
US-9791399-B2 Derivatization of carbon SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2017-10-17 — — US disclosed
US-20140332412-A1 DERIVATIZATION OF CARBON SCHLUMBERGER TECHNOLOGY COPORATION (US) 2014-11-13 — — US disclosed
US-5484706-A Immunoassay for analytes in samples using alkylating agents PASTEUR SANOFI DIAGNOSTICS (FR) 1996-01-16 — — US disclosed
US-5426055-A Quantitative analysis VALENCE TECHNOLOGY, INC. (US) 1995-06-20 — — US disclosed
EP-0385442-B1 Positive-working photoresist composition FUJI PHOTO FILM CO LTD (JP) 1994-06-01 — — EP disclosed
US-5130224-A Naphthoquinonediazide and a light absorbers FUJI PHOTO FILM CO., LTD. (JP) 1992-07-14 — — US disclosed
US-5055195-A Coagulation, filtration, separation form whole blood; having two strongly polar groups separated by aromatic or heteroaroma tic rings BOEHRINGER MANNHEIM GMBH (DE) 1991-10-08 — — US disclosed
EP-0385442-A1 Positive-working photoresist composition FUJI PHOTO FILM CO., LTD. (JP) 1990-09-05 — — EP disclosed
US-4058607-A DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES AIRWICK INDUSTRIES, INC. (US) 1977-11-15 — — US disclosed
US-3966900-A INSECTICIDES AIRWICK INDUSTRIES, INC. (US) 1976-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140332412-A1 DERIVATIZATION OF CARBON FTH1, CBR1, SDHB TDP1 4720/4885ALDH1A1 162/4885SMN1; SMN2 4435/4885
US-20060173058-A1 Kcnq channel modulating compounds and their pharmaceutical use KCNQ1, KCNQ2, KCNQ5 TDP1 4573/4885ALDH1A1 4394/4885SMN1; SMN2 2692/4885
US-11384381-B2 Reaction accelerating agent MPO, AOX1, MAOA TDP1 1071/4885ALDH1A1 151/4885SMN1; SMN2 2225/4885
US-20190316174-A1 REACTION ACCELERATING AGENT MPO, AOX1, MAOA TDP1 1071/4885ALDH1A1 151/4885SMN1; SMN2 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.